Abstract:One of the hallmark features in the neurodegenerative disorders (NDDs) is the accumulation of aggregated and/or non-functional protein in the cellular milieu. Post-translational modifications (PTMs) are an essential regulator of non-functional protein aggregation in the pathogenesis of NDDs. Any alteration in the post-translational mechanism and the protein quality control system, for instance, molecular chaperone, ubiquitin-proteasome system, autophagy-lysosomal degradation pathway, enhances the accumulation of misfolded protein, which causes neuronal dysfunction. Post-translational modification plays many roles in protein turnover rate, accumulation of aggregate and can also help in the degradation of disease-causing toxic metabolites. PTMs such as acetylation, glycosylation, phosphorylation, ubiquitination, palmitoylation, SUMOylation, nitration, oxidation, and many others regulate protein homeostasis, which includes protein structure, functions and aggregation propensity. Different studies demonstrated the involvement of PTMs in the regulation of signaling cascades such as PI3K/Akt/GSK3β, MAPK cascade, AMPK pathway, and Wnt signaling pathway in the pathogenesis of NDDs. Further, mounting evidence suggests that targeting different PTMs with small chemical molecules, which acts as an inhibitor or activator, reverse misfolded protein accumulation and thus enhances the neuroprotection. Herein, we briefly discuss the protein aggregation and various domain structures of different proteins involved in the NDDs, indicating critical amino acid residues where PTMs occur. We also describe the implementation and involvement of various PTMs on signaling cascade and cellular processes in NDDs. Lastly, we implement our current understanding of the therapeutic importance of PTMs in neurodegeneration, along with emerging techniques targeting various PTMs.

Protein kinases and the functional regulation in the nervous system: a review of illustration with examples

An Artificial Protein Modulator Reprogramming Neuronal Protein Functions

Protein Kinase A in neurological disorders

Structure, Regulation, and (Patho-)Physiological Functions of the Stress-Induced Protein Kinase CK1 Delta (CSNK1D).

Modulation of Neurotransmitter Release and Presynaptic Plasticity by Protein Phosphorylation

Pleiotropic functions of TAO kinases and their dysregulation in neurological disorders

The Extracellular Signal-Regulated Kinase 1/2 Pathway in Neurological Diseases: A Potential Therapeutic Target (Review)

Abnormal phosphorylation of protein tyrosine in neurodegenerative diseases

[P21-Activated Kinases and Their Role in the Nervous System].

Getting smart - Deciphering the neuronal functions of protein kinase D

Post-translational Modifications of Neurodegenerative Disease Proteins

Protease Regulation: the Yin and Yang of Neural Development and Disease

Post-translational modifications: Regulators of neurodegenerative proteinopathies

Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis

Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters

Nuak kinase signaling in development and disease of the central nervous system

Current Technologies Unraveling the Significance of Post-Translational Modifications (PTMs) as Crucial Players in Neurodegeneration

Protein modification in neurodegenerative diseases

The 14-3-3 Proteins as Important Allosteric Regulators of Protein Kinases

Modulation of Neurotransmitter Release by the Second Messenger-Activated Protein Kinases: Implications for Presynaptic Plasticity.

The lemur tail kinase family in neuronal function and disfunction in neurodegenerative diseases